Professor Agnes Borge Fogo completed her medical and pathology training at Vanderbilt University, Nashville, TN, USA.
Her main research interests are focused on progression of chronic kidney disease and crosstalk between tubules and glomeruli, funded by the NIH and other sources.
She has created an online Atlas of Renal Pathology with AJKD and NKF, and published two renal pathology books.
She received the Robert G. Narins award from the ASN and the Roscoe R. Robinson award from the ISN for her contributions in teaching.
She has been a councilor of the ISN, served as Chair of its Renal Pathology Committee, with focus on developing educational tools related to kidney biopsy interpretation.
She started her 2 year term as the President of the ISN at the 2021 WCN meeting. She is currently the John L.
Shapiro Professor of Pathology, Microbiology and Immunology, Professor of Medicine and Pediatrics and director of the Renal/Electron Microscopy Laboratory, at Vanderbilt University Medical Center.
Claudio Ronco is Full Professor of Nephrology at the University of Padova, Italy. He is also director of the Department of Nephrology and the International Renal Research Institute(IRRIV) of San Bortolo Hospital, Vicenza, Italy.
He graduated in 1976 and specialised in nephrology at the University of Padua in 1979.
He has been Director of the Laboratory of the RRI and Beth Israel MC in New York and professor of Medicine at the Albert Einstein College of Medicine. He is external professor at the University of Virginia of Charlottesville and the University Fudan and Jaotong of Shanghai. He received the Honorary degree at the University of Patras.He authored 1687 papers, 95 books and 205 book chapters and delivered more than 900 lectures at international meetings. His H-index is 124. He is Editor-in-Chief of Blood Purification, Contributions to Nephrology, Cardiorenal Medicine and Editor emeritus of the International Journal of Artificial Organs. He has received several international awards. He is considered a pioneer in many areas of nephrology including peritoneal dialysis, critical care nephrology, CRRT, cardiorenal syndromes and wearable dialysis technology. He invented the first CRRT machine for neonates CARPEDIEM (Cardio Renal Pediatric Dialysis Emergency Machine). He founded the international ADQI consensus group and the International Renal Research Institute of Vicenza (IRRIV) wher he trained more than 200 international fellows. Internationally known are his contributions in Cardiorenal Medicine, Critical Care Nephrology, Pediatric Nephrology, Hemodialysis and Peritoneal dialysis, Membrane and Dialysis Device- related bioengineering.
Fernando C. Fervenza, MD. D.Phil (Oxon – Jesus College). Is a Professor of Medicine at the Mayo Graduate School of Medicine, Rochester, MN, USA. He graduated in Medicine at the Pontificia Universidade Catolica do Rio Grande do Sul, Brasil. He underwent his clinical nephrology and research training at Oxford University and Oxford Renal Unit, England, from 1985 to 1991. Subsequent training included Post-doctoral Fellowship at Stanford University, USA (1993-1997). He is a Fellow of the American Society of Nephrology, Fellow of the American College of Physicians, past Member of the American Board of Internal Medicine, Nephrology section, Up-To-Date Section Editor for Glomerular Disease. His area of interest is in pursuing patient-oriented research projects aiming to bring new bench research discoveries to the bedside treatment of patients with glomerular diseases.
Professor of Paediatric Nephrology at the UCL Department of Renal Medicine and Honorary Consultant Nephrologist and clinical lead for nephrology at Great Ormond Street Hospital for Children NHS Foundation Trust, UK
Dr. Hildebrandt is the William E. Harmon Professor at Harvard Medical School, and chief of the Division of Nephrology at Boston Children’s Hospital.
His research work is concerned with the identification and functional characterization of single-gene causes of chronic diseases of the kidney, the eye and the auditory system in children. His group has developed high-throughput sequencing approaches, identified 80 novel disease genes, of the currently 240 known monogenic causes of chronic kidney disease.
When studying the function of these newly identified disease genes in models of mice, zebrafish and drosophila, as well as in cell-based systems they discovered multiple novel pathogenic mechanisms of kidney disease. For instance, his lab discovered that DNA damage repair plays a role in the pathogenesis of organ fibrosis.
Dr. Hildebrandt’s work interphases with 200 nephrologists and 10,000 patient families worldwide. The research work of his lab has been supported by grants from the NIH, a grant as a Doris Duke Distinguished Clinical Scientist, the March of Dimes, and the Thrasher Research Foundation.
Johannes F. E. Mann, M.D., is currently (since 1989) full Professor of Medicine at the University of Erlangen-Nürnberg and Head, KfH Kidney Center, Munich, both in Germany. He is also (since 2010) International Scholar at Population Health Research Institute, McMaster University, Canada.
His previous assignments include Director of Dept. of Nephrology, Munich General Hospitals, staff member and assistant Professor of Medicine, Dept. of Medicine, University of Heidelberg, Germany, and research fellowships in Pharmacology at the Universities of Montreal, Canada and of Heidelberg, Germany.
Professor Mann, a board-certified specialist in Internal Medicine, in Nephrology, in Intensive Care and in Pharmacology and Toxicology, was an officer of the German Societies of Medicine and of Nephrology, of the International Society of Nephrology and is on the editorial board of major journals of nephrology.
Professor of Critical Care Medicine, Medicine, Bioengineering and Clinical and Translational Science at the University of Pittsburgh; and Chief Medical Officer, Spectral Medical, USA
Dr. Joseph Flynn is the Dr. Robert O. Hickman Endowed Chair in Pediatric Nephrology, Professor of Pediatrics, University of Washington, and Chief, Division of Nephrology, Seattle Children’s Hospital. He completed his pediatric nephrology training at St. Christopher’s Hospital for Children in Philadelphia, PA, and later received an MS in Clinical Research from the Albert Einstein College of Medicine, Bronx, NY. During his fellowship training, Dr. Flynn obtained experience in clinical research under the guidance of Drs. Bruce Kaiser and Jorge Baluarte and worked in the laboratory of Dr. Bonita Falkner at the Medical College of Pennsylvania. He is an internationally recognized expert in the treatment of hypertension in children, and recently chaired the American Academy of Pediatrics Subcommittee that developed the updated clinical practice guideline on high blood pressure in children and adolescents.
Dr. Flynn served on the Council of the International Pediatric Nephrology Association from 2010-2019, and also on the Council of the American Society of Pediatric Nephrology, including 2 years as ASPN President (2012-14). He currently is a Board Member of the Renal Physicians Association and a member of the Nephrology sub-board of the American Board of Pediatrics. In addition to these activities, Dr. Flynn has published over 160 peer-reviewed papers and over 110 textbook chapters, invited reviews and editorials. He currently serves as one of the Editors-in-Chief of IPNA’s journal, Pediatric Nephrology. He has trained over 50 nephrology fellows, most of whom have faculty appointments at academic institutions, and several who currently hold leadership positions within various pediatric nephrology organizations.
Consultant nephrologist at Sheffield Teaching Hospitals NHS Foundation Trust from August 1995; Editor in Chief Peritoneal Dialysis International 2013-2020; Chief Investigator UK Catheter study (peritoneal dialysis access), Clinical Lead for the Health Foundation funded Shared Haemodialysis Care Programme from 2010; Strategy lead Yorkshire and Humber NIHR Clinical Research Network.
Martin has run a home dialysis service at Sheffield since 1995 including both home haemodialysis and peritoneal dialysis. As home therapies lead for Yorkshire and Humber Renal Network in 2010 he established Shared Haemodialysis Care – a Health Foundation funded programme that supports people who dialyse at centres to learn treatment related tasks – this has been widely adopted across the UK and has drawn international attention.
Professor of Medicine at the University of British Columbia, Canada
He is the founder and C.E.O. of Syreon Corporation, a global research corporation specializing in the use of advanced information technologies for health sciences research.
Nephrologist working in London, Ontario.
He is a professor of Medicine and former chair of the Division of Nephrology at Western University and London Health Sciences Centre, Canada
Rukshana Shroff is a Professor of Paediatric Nephrology at Great Ormond Street Hospital for Children and University College London, UK. Her research focuses on bone and cardiovascular disease in childhood CKD and improving outcomes for children on dialysis. She holds a prestigious senior fellowship from the National Institute for Health Research (NIHR).
Professor Shroff is co-editor for the 8th edition of Pediatric Nephrology, the definitive textbook in our field. She was elected to serve as a member of the KDIGO Kidney Disease: Improving Global Outcomes (KDIGO) Executive Committee and works on international guideline committees for KDIGO, NICE and ESPN. She serves on the editorial board of several journals and has published over 250 original articles, reviews and editorials. She has contributed to the scientific committee of several international meetings.
Professor Shroff is an Educational Ambassador for the ISN and currently manages 3 sister renal centres across India and Vietnam.
Dr. Rupesh Raina is an Adult-Pediatric Kidney Disease/Hypertension Nephrologist at Akron Children’s Hospital, and Akron General Medical Center at Cleveland Clinic Foundation. He is a Associate Professor at Neomed Medical University and Case Western Reserve University, Cleveland, Ohio. He is Council member for Facility of Internal Medicine Council at Neomed. Dr. Raina is the Pediatric Education committee member for the International Society of Nephrology. He is Fellow of National Kidney Foundation and American Society of Nephrology. Additionally, Dr. Raina serves the National Kidney Foundation Advisory Board NKF, Ohio.. Dr. Raina practice includes care of patients with disorders of the kidney including chronic kidney disease, nephrotic syndrome, glomerulonephritis, tubular disorders, cystic kidney disease, kidney malformations, neonatal AKI, kidney stones and hypertension. He also and provides medical supervision of dialysis treatments, plasma exchange and kidney transplantation in adults and children. Dr. Raina’s clinical research interest includes transition of adolescent with chronic renal diseases to adulthood care, renal replacement therapies in acute renal failure, bone marrow transplant and inherited metabolic diseases. Basic science research includes but not limited to identify non-invasive biomarkers (urine endothelin (ET-1) and others) to predict ADPKD disease progression.
Dr. Sanjeev Sethi graduated from Assam Medical College, India. He pursued graduate studies thereafter at Albany Medical College, NY, and received his Ph.D. in Experimental Pathology in 1995. Subsequently, Dr. Sethi completed his Pathology residency at Yale University (1995-1999) and his fellowship in Renal Pathology at Brigham and Women’s Hospital, Harvard University (1999-2001). He is currently a Professor at Mayo Clinic, Rochester. His primary interests and research are in: 1) Glomerulonephritis, with a focus on the approach to glomerulonephritis, the role of monoclonal gammopathy in glomerulonephritis, and the role alternative pathway of complement in glomerulonephritis, 2) Application of proteomics in renal pathology. New diseases have been identified using this novel approach. These include identification of new types of amyloidosis and novel antigens in membranous nephropathy. These studies have resulted in over 250 peer-reviewed publications.
Prof. Vladimir Tesar, MD, PhD, MBA, FERA, FASN, born May 5, 1957,
Head, Department of Nephrology, 1st Faculty of Medicine, Charles University.
member of the Executive Committee of ISN Council and the chair of the CEE board
Member of the board of KDIGO guidelines for glomerulonephritis 2021
Substantial part of the publications deals with diagnosis and treatment of glomerulonephritides, mainly ANCA-positive vasculitis and lupus nephritis, IgA and membranous nephropathy and FSGS, renal and renovascular hypertension, and autosomal dominant polycystic kidney disease (and other genetic diseases of the kidney) and cardiovascular complications of renal failure.
Dr. Vikas Dharnidharka is the Chief of the Division of Pediatric Nephrology, Hypertension and Pheresis at Washington University in St Louis. He is also the Vice-Chair for Clinical Investigation in the Department of Pediatrics and a tenured Professor of Pediatrics.
As a clinical and translational researcher, Dr. Dharnidharka creates and leads multidisciplinary teams that perform many different types of research, ranging from translational metagenomic sequencing projects, to large database integrations for comparative effectiveness, to clinical biomarker studies. His areas of focus are post-transplant infections and malignancies, in particular PTLD and BK virus nephropathy. He has published more than 200 papers, including in the New England Journal of Medicine, Journal of Clinical Investigation and Lancet Infectious Diseases. He has received NIH salary support continuously since 2004.
He is the current chair of the Section of Nephrology within the American Academy of Pediatrics, and serves on the National Governing Council of the American Society of Pediatric Nephrology.